跳至主要内容
临床试验/NCT02687347
NCT02687347Unknown3 期

A Double Blind Randomized Clinical Trial to Investigate the Efficacy and Safety of Ultra-low Dose Methadone as Adjuvant Analgesic Therapy in Cancer Patients With Pain

McGill University Health Centre/Research Institute of the McGill University Health Centre1 个研究点 分布在 1 个国家目标入组 204 人开始时间: 2016年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
204
试验地点
1
主要终点
pain relief

研究概览

简要总结

The research hypothesis of this study is: In patients with moderate to severe cancer related pain, the addition of low dose methadone to an existing opioid significantly reduces pain severity compared to low doses morphine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed of cancer-related pain of more than 3 months duration
  • Pain relief during the last week rated unsatisfactory by the patient
  • Pain severity during the last week rated moderate (between 4 and 7/10)
  • Analgesic therapy must have been stable for 7 days
  • Able to understand English or French
  • Willing and able to give written informed consent

排除标准

  • Patients who are currently receiving or have received methadone as analgesic in the last 6 months
  • Contraindication to receive methadone (allergy, QTc segment on the ECG>450msec, concurrent treatment with medication that could increase methadone's effects)
  • Patients presenting with changes in their cancer status/treatment with potential effects on their pain severity, during the duration of the trial (eg: new metastasis, indication for radiotherapy)
  • Patients whose life expectancy is shorter than 2 months
  • Patients with cognitive impairment presenting with difficulties understanding the trial and completing the research questionnaires
  • Pregnant or lactating women (women of childbearing potential must have negative pregnancy test)

研究组 & 干预措施

study arm

Experimental

low dose methadone (1-10mg daily)

干预措施: oral methadone (Drug)

control arm

Active Comparator

low dose morphine (1-10 mg/day)

干预措施: oral morphine (Drug)

结局指标

主要结局

pain relief

时间窗: 2 months

Questions 3 to 6 of the Brief Pain Inventory

次要结局

  • Number of participants with treatment-related adverse events as assessed by CTCAE v4.0".(2 months)

研究者

发起方
McGill University Health Centre/Research Institute of the McGill University Health Centre
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jordi Perez

Codirector Cancer Pain Program. McGill University Health Centre. Montreal, Canada

McGill University Health Centre/Research Institute of the McGill University Health Centre

研究点 (1)

Loading locations...

相似试验